Kenneth Oglesby, DPM
Podiatrist · Bloomington, INNPI 1285735712
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Stryker accounts for 75.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $705 and has fallen 74.3% since, to $181 in 2025.
Across 21 payments — averaging $88.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Kerecis Limited$327
- Averitas Pharma Inc.$46
- Smith+Nephew$40
- Inari Medical, Inc.$39
What the payments were for
- Food & beverage$1,858100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 14 | $1,407 |
| Kerecis Limited | 2 | $327 |
| Averitas Pharma Inc. | 2 | $46 |
| Smith+Nephew | 2 | $40 |
| Inari Medical, Inc. | 1 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$576
- Kerecis SurgiClose$540
- EASYFUSE$283
- VARIAX$269
- Kerecis Omega3 GraftGuide$192
- Kerecis Omega3 Marigen$192
- PROPHECY$175
- INFINITY$175
- Kerecis GraftGuide$135
- HOFFMANN$125
- ORTHOLOC 3DI$108
- ORTHOLOC 2 LAPIFUSE$102
How this compares
$1,858 in reported general payments places this provider in the 55th percentile of 131 podiatrist providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 264 | $3,784 |
| CiclopiroxCiclopirox Olamine | 67 | $2,270 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 76 | $740 |
| Ammonium Lactate | 22 | $653 |
| Methylprednisolone | 102 | $635 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 47 | $553 |
| Cephalexin | 89 | $493 |
| Mometasone Furoate | 20 | $464 |
| Fluconazole | 17 | $407 |
| Clindamycin Hcl | 16 | $162 |
| Meloxicam | 49 | $130 |
| Gabapentin | 13 | $103 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Bloomington
- Andrew RaderJasper$726K
- Anthony MillerIndianapolis$292K
- Corey GrohIndianapolis$57K
- Jeffrey StevensIndianapolis$56K
- James VestileTipton$44K
- Andrew KapsalisAvon$37K
- Scott HoffmanAvon$22K
- John RachoyMunster$21K
- Townsen KenningtonFort Wayne$20K
- Jared MoonCrown Point$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.